tiprankstipranks
Esperion (ESPR)
NASDAQ:ESPR

Esperion (ESPR) Stock News & Sentiment

1,289 Followers
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity
PremiumPress Releases
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity
14d ago
Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024
PremiumPress Releases
Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024
21d ago
Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference
PremiumPress Releases
Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference
27d ago
Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24
PremiumPress Releases
Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24
27d ago
U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
PremiumPress Releases
U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
1M ago
CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And Significantly Reducing Cardiovascular Events
PremiumPress Releases
CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And Significantly Reducing Cardiovascular Events
1M ago
Esperion Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
Esperion Reports Fourth Quarter and Full Year 2023 Financial Results
2M ago
More ESPR News >

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ESPR’s Media Buzz Sentiment?
Currently, no data Available
What is ESPR’s weekly average amount of articles?
Currently, no data Available
What is ESPR’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
ELVElevance Health
EWEdwards Lifesciences
INSPInspire Medical Systems
CGEMCullinan Management
MRNSMarinus
Showing the stocks with the most bullish news sentiment over the past week
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis